DCM Shriram Limited — Investor Meet, 11-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:** DCM Shriram Limited reported net revenues of ₹2,957 Cr for Q2 FY25, marking a 9% increase year-on-year, driven by robust growth in chemicals, Shriram Farm Solutions (SFS), and bioseed sectors. PBDIT surged 73% to ₹235 Cr. Chemicals led the performance with a 19% revenue increase, primarily from caustic soda due to new capacity. However, the vinyl segment suffered an 8% revenue drop, attributed to planned maintenance. The sugar and ethanol segment exhibited modest growth, with revenues up by 3%, while Fenesta's revenues grew 6%, despite rising fixed expenses.

**Future Outlook and Growth Drivers:** Management emphasized strategic growth via backward and forward integration, focusing on sustainability through renewable energy projects totaling 74 MW. They are poised to capitalize on favorable market conditions in chemicals, expect improvements in domestic PVC demand, and anticipate a boost from anti-dumping duties.

**Order Book and Operational Updates:** Upcoming projects include a ₹310 Cr investment in chlorine downstream projects and a new aluminum extrusion facility, expected to enhance exports and reduce costs. The ECH plant is on track for commissioning by Q4 FY25, with other expansions progressing.

**Analyst Q&A Insights (Detailed):** Management clarified that captive chlorine consumption could rise significantly with projected capacity utilization. Analysts expressed concerns about competitive pressures from upcoming projects in PVC, which management addressed by highlighting a gap in domestic supply.

**Market or Regulatory Updates:** Analysts inquired about the potential impact of the recommended anti-dumping duty for PVC imports, to which management expressed optimism regarding profitability enhancements.

**Strategic Focus Areas:** Focus remains on operational agility, cost efficiency, and sustainability. Management is confident in navigating competitive market dynamics while emphasizing internal cost control.

**Investor Insight:** Financial health indicators and strategic positioning suggest a cautious optimism towards holding shares, contingent on effective implementation of growth strategies and monitoring emerging competitors.